Speed, equity vital in advancing global heart health
To improve heart health worldwide, science must move more quickly and equitably into clinical practice, American Heart Association leaders said this summer at the European Society of Cardiology Congress 2026 in Munich.
On topics including equitable health, cardiovascular disease in women, artificial intelligence and clinical trials, Heart Association leaders noted that strong science may be at center stage, but progress relies on supporting players, too. These include technology, quality improvement and global collaboration.
In a joint session with the ESC, American College of Cardiology and World Heart Federation, Heart Association President Manesh Patel(link opens in new window), MD, FAHA, noted that AI must prioritize equitable access, representative data and thoughtful implementation.
“AI systems learn from the data and the healthcare system we already have, including its inequities,” he said. Through the Association’s Precision Medicine Platform and the SYMPHONY Consortium, a collaboration with Duke Clinical Research Institute, AI could also help broaden access to health data and support cardiovascular care.
Learn more about the Association’s international initiatives(link opens in new window).